NEDC e-Bulletin Issue Five | November 2012 Editors Note: Welcome to the November issue of the NEDC e-Bulletin.
Read moreNEDC e-Bulletin In our weight-conscious society, we sometimes forget that the whole world doesn't see the body the way we do (Becker, 1995).
Read moreGlucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.
Read moreTheory and Practice: Screening and Assessment Tools for Eating DisordersEditor's Note: Welcome to this edition of the NEDC e-Bulletin, where we delve into the NEDC’s recent and upcoming collaborations with local PHNs and then examine different practical screening and assessment tools to help you detect the possible presence of an eating disorder.
Read more